Investment Thesis — Dow Inc.
The market is mispricing Dow by fixating on its current trough-cycle financials, failing to recognize the forward-looking signals of a robust cyclical recovery already reflected in recent price action. We believe the consensus is buying a lagging narrative while the underlying demand dynamics are poised for a significant rebound.
Catalysts
- Stronger-than-expected Q1/Q2 2024 earnings showing positive EPS or significant margin improvement.
- Positive macro indicators for industrial production and manufacturing PMIs signaling demand recovery.
- Successful completion of inventory destocking across key end markets, boosting order volumes.
Risk Factors
- Prolonged global economic slowdown or deeper-than-expected recession impacting industrial demand.
- Further deterioration in commodity chemical prices due to oversupply or weak demand.
- Unexpected operational issues or higher input costs eroding potential margin recovery.
Key Debates
DOW's Fwd P/E drops below 20x by Q4 on volume recovery.
Analyst PT rises above $40 by Q3, validating market optimism.
DOW's revenue growth exceeds 5% by Q4 on demand surge.